España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
RxSight
RXST
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
RxSight (RXST) Forecast
News
Earnings
RxSight (RXST) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for RxSight (NASDAQ:RXST) Stock
RxSight Stock (NASDAQ: RXST)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 08, 2024
RxSight shares are trading lower. The company...
Benzinga Newsdesk
Thursday, November 07, 2024
RxSight shares are trading lower. The company...
Benzinga Newsdesk
RxSight Now Sees FY24 Revenue At The Top Of P...
Benzinga Newsdesk
RxSight Q3 2024 Adj EPS $0.00 Beats $(0.25) E...
Benzinga Newsdesk
Tuesday, October 29, 2024
This Six Flags Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Avi Kapoor
Analyst Scoreboard: 7 Ratings For RxSight
Benzinga Insights
Jefferies Initiates Coverage On RxSight with ...
Benzinga Newsdesk
Friday, September 13, 2024
Peeling Back The Layers: Exploring RxSight Through Analyst Insights
Benzinga Insights
Needham Reiterates Buy on RxSight, Maintains ...
Benzinga Newsdesk
Tuesday, August 20, 2024
Needham Maintains Buy on RxSight, Raises Pric...
Benzinga Newsdesk
Tuesday, August 06, 2024
Deep Dive Into RxSight Stock: Analyst Perspectives (6 Ratings)
Benzinga Insights
Wells Fargo Maintains Overweight on RxSight, ...
Benzinga Newsdesk
Lithia Motors To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
RxSight Analysts Slash Their Forecasts After Q2 Results
Avi Kapoor
Oppenheimer Maintains Outperform on RxSight, ...
Benzinga Newsdesk
Stifel Maintains Buy on RxSight, Lowers Price...
Benzinga Newsdesk
RxSight shares are trading higher after the c...
Benzinga Newsdesk
Needham Maintains Buy on RxSight, Lowers Pric...
Benzinga Newsdesk
Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, August 05, 2024
RxSight Raises FY24 Revenue Forecast From $13...
Benzinga Newsdesk
RxSight Q2 Sales $34.887M Beat $32.283M Estim...
Benzinga Newsdesk
Tuesday, July 16, 2024
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
Chris Katje
Monday, July 15, 2024
RxSight Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Benzinga Insights
BTIG Maintains Buy on RxSight, Raises Price T...
Benzinga Newsdesk
Wednesday, July 10, 2024
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
RxSight shares are trading lower after Stifel...
Benzinga Newsdesk
Stifel Maintains Buy on RxSight, Lowers Price...
Benzinga Newsdesk
Thursday, May 23, 2024
Buy 5 Medical Instruments Stocks to Enhance Your Portfolio
Zacks
Thursday, May 09, 2024
Why RxSight (RXST) Shares Are Falling
Henry Khederian
Reported Earlier, RxSight Prices Public Offer...
Benzinga Newsdesk
Wednesday, May 08, 2024
RxSight shares are trading lower after the co...
Benzinga Newsdesk
RxSight Announces $100M Proposed Public Offer...
Benzinga Newsdesk
Tuesday, May 07, 2024
Wells Fargo Maintains Overweight on RxSight, ...
Benzinga Newsdesk
What 10 Analyst Ratings Have To Say About RxSight
Benzinga Insights
RxSight shares are trading higher after the c...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on RxSight, ...
Benzinga Newsdesk
Needham Maintains Buy on RxSight, Raises Pric...
Benzinga Newsdesk
BTIG Maintains Buy on RxSight, Raises Price T...
Benzinga Newsdesk
Monday, May 06, 2024
RxSight Raises 2024 Revenue Guidance From $12...
Benzinga Newsdesk
RxSight Q1 2024 Adj EPS $(0.12) Beats $(0.27)...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Stifel Maintains Buy on RxSight, Raises Price...
Benzinga Newsdesk
Thursday, April 11, 2024
Assessing RxSight: Insights From 8 Financial Analysts
Benzinga Insights
Needham Reiterates Buy on RxSight, Maintains ...
Benzinga Newsdesk
Thursday, February 29, 2024
Stifel Maintains Buy on RxSight, Raises Price...
Benzinga Newsdesk
JP Morgan Maintains Overweight on RxSight, Ra...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on RxSight, ...
Benzinga Newsdesk
Forecasting The Future: 9 Analyst Projections For RxSight
Benzinga Insights
Needham Maintains Buy on RxSight, Raises Pric...
Benzinga Newsdesk
Wednesday, February 28, 2024
RxSight Sees FY24 Revenue $128M-$135M Vs $126...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch